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ABSTRACT
BACKGROUND: Congenital heart defects include a wide range of inborn malformations. 
Depending on the defect, the life expectancy of a newborn with cardiac anomaly varies 
from a few days to a normal life span. In most instances surgery, is the only treatment 
available. The late results of surgery have not been comprehensively investigated. 
AIMS: Mortality, morbidity and the life situation of all Finnish patients who had been 
operated on for congenital heart defect during childhood were investigated.
METHODS: Patient and surgical data were gathered from all hospitals that had 
performed heart surgeries on children. Late mortality and survival data were obtained 
from the population registry, and the causes of deaths from Statistics Finland. Morbidity 
of patients operated on during 1953–1989 was assessed by the usage of medicines. 
The pharmacotherapy data of patients and controls were obtained from the Social 
Insurance Institute. The life situation of patients was surveyed by mailed questionnaire. 
Survival, causes of deaths and life situation of patients were compared with those of 
the general population.
RESULTS: A total of 7240 cardiac operations were performed on 6461 children during 
the first 37 years of cardiac surgery (1953–1989). The number of procedures constantly 
rose during this period, and the increase continued in later years. The patient material 
varied over time, as more defects became surgically treatable.
During 1953-1989 the operative mortality (death within 30 days of surgery) was 6.9%. 
In the 1990s a slight rise occurred in early mortality, as increasingly complicated 
patients were surgically treated. During 2000–2003 practically no defects were beyond 
the operative range. Thus, the operative mortality of 4.4% was excellent, decreasing 
even further to 2.0% in 2004–2007.
The overall 45-year survival of patients operated on in 1953–1989 was 78%, and the 
corresponding figure for the general population was 93%. Survival depended on the 
defect, being worst among patients with univentricular heart. Late survival was also 
better during the 1990s and at the beginning of the 21st century. 
Of the 6028 early survivors, 592 died late (>30 days) after surgery. A total of 397 
deaths (67%) were related and 185 (31%) unrelated to congenital heart defect. The 
cause of death was unknown in 10 cases.
Of those 5774 patients who survived their first operation and had complete follow-up, 
16% were operated on several times. Seventeen percent of patients used medicines 
for cardiac symptoms (heart failure, arrhythmia, hypertension and coronary disease). 
Patients’ risk of using cardiac medicines was 2.16 (Cl 1.97–2.37) times higher than 
that of controls. Patients also had more genetic syndromes and mental retardation and 
more often used medicines for asthma and epilepsy.
Adult patients who had been operated on as children had coped surprisingly well with 
their defects. Their level of education was similar and their employment level even 
higher than expected, and they were living in a steady relationship as often as the 
general population. 
CONCLUSIONS: Cardiac surgery developed rapidly, and nowadays practically all 
defects can be treated. The overall survival of all operated patients was 78%, 16% 
less than that of the general population. However, it was significantly better than 
the anticipated natural survival. However, many patients had health problems; 16% 
needed reoperations and 17% cardiac medicines to maintain their condition. Most of 
the patients assessed their general health as good and lived a normal life.
We are making history every day
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ABBREVIATIONS
AS	 	 Aortic	stenosis
ASD		 	 Atrial	septal	defect
CHD	 	 Congenital	heart	defect
Cl	 	 Confidence	inteval
COA	 	 Coarctation	of	aorta
ESR	 	 Entitlement	for	special	reimbursement
NYHA	 	 New	York	Heart	Association’s	exercise	capacity	classification
PDA	 	 Patent	ductus	arteriosus
RR	 	 Risk	ratio
SMR	 	 Standardized	mortality	ratio
TGA	 	 Transposition	of	the	great	arteries
TOF		 	 Tetralogy	of	Fallot
UVH	 	 Univentricular	heart
VSD	 	 Ventricular	septal	defect
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INTRODUCTION
Five hundred children are born with a congenital heart disease (CHD) in Finland each 
year (Louhimo 1979, Minkkilä et al. 1996). Depending on the defect, the life expectancy 
of a newborn varies from a few days to a normal life span (Samanek 1992). In most 
instances, surgery is the only treatment available. Paediatric cardiac surgery began in 
1938 with closure of patent ductus arteriosus (PDA). Since then, advancements have 
been rapid. Practically all CHD patients can be cured or palliated today – “inoperable” 
cases are very rare. 
The first paediatric heart operation in Finland was performed on 29 April 1953. The 
patient was a 5-year-old boy with PDA. Several decades and thousands of patients 
later, many questions have arisen: Are the operated patients still alive? How long did 
they live? And if still alive, how are they doing? Were they able to study, work and raise 
a family? 
Answers to some of these questions have been reported by special cardiac centres 
around the Western world, but the patient populations have been selected and 
numerous patients have been lost from follow-up. 
In Finland, good cooperation exists between the hospitals treating paediatric cardiac 
patients, and a reliable population registry is available. These two facts have enabled 
the first population-based study including, all paediatric patients operated on for CHD 
with a nearly complete follow-up. 
The research registry used in this study was founded in 1995. In this thesis, I present 
the late results of the patients operated on during 1953–1989, and also some data of 
the newer era of surgery. The new data highlight the progression of the treatment of 
congenital heart defects.
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REVIEW OF THE LITERATURE
Congenital heart defects
Congenital heart defects include a wide range of inborn malformations. The incidence 
of a heart defect is about 1% among live-born infants (Hoffman 1995). The structure of 
a normal heart and the most common defects are presented schematically in Figure 1.
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Left
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ventricle
Right
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ventricle
Superior 
vena 
cava
Inferior
vena 
cava
Pulmonary 
veins
Pulmonary 
veins
1
2 34
1 Tricuspid valve
2 Pulmonary valve
3 Mitral valve
4 Aortic valve
Normal heart Ventricular septal Patent ductus
defect arteriosus
99% 0.31% 0.07%
Tetralogy of Transposition of the Univentricular Hypoplastic left
Fallot great arteries heart heart syndrome
0.06% 0.05% 0.03% 0.03%
Atrial septal Coarctation of
defect aorta
0.07% 0.06%
Figure 1. Schematic illustrations of a heart of normal structure and the most common 
congenital lesions. The incidence of each structure at birth is presented above each 
illustration (Hoffman 1995). The incidence of univentricular heart includes the incidence 
of tricuspid atresia (presented in picture), single ventricle and hypoplastic right heart.
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Natural survival
Natural survival, i.e. survival without surgical or any intervention treatment, varies 
widely. Some defects lead to death within hours after birth and even more often 
a complex heart defect of the foetus leads to miscarriage. At the other end of the 
spectrum are milder defects, the most common being ventricular septal defect (VSD) 
which often closes spontaneously (Kirklin et al. 1993b). However, if the VSD is large, 
it will cause pulmonary hypertension, leading to Eisenmenger’s syndrome, and these 
patients usually die during the third decade of life (Kirklin et al. 1993b). 
The 15-year natural survival of all patients with cardiac defects has been estimated to 
be 67% (Samanek 1992). The natural survival in different diagnostic groups according 
to Kirklin et al. (Kirklin et al. 1993a) is presented in Table 1.
Diagnosis Survival (%)
1-year 15-year 45-year
Patent ductus arteriosus 70 65 35
Atrial septal defect 99 90 32
Ventricular septal defect (large) 91 90 20
Coarctation of aorta 70 42 15
Tetralogy of Fallot 75 19 1
Transposition of the great arteries 10 1
Univentricular heart (tricuspid atresia) 3–75 0–3
Table 1. Natural survival in different diagnostic groups.
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Cardiac surgery
History
Cardiac surgery began in 1938, when Gross successfully closed a PDA. Six years 
later, Craford and Nylin were able to correct coarctation of the aorta (COA). In 1945, 
the first tetralogy of Fallot (TOF) patients were palliated with a Blalock-Taussig shunt. 
In the late 1940s and early 1950s the first infants with PDA and COA were surgically 
treated. At the same time, it was noted that superficial cooling and hypothermia could 
be used to enable circulatory arrest. In 1953, the first patients with atrial septal defect 
(ASD) were corrected with this method. 
The next huge step was taken in 1954, when the first patients with VSD and TOF were 
repaired using cross-circulation, with another human serving as an oxygenator. But it 
was only when the first successful operations with a mechanical heart-lung machine 
were performed in 1955 that advancements in cardiac surgery really exploded. 
Following these landmarks of cardiac surgery, the development has continued steadily. 
Different spare parts for heart and different methods for repairing have been invented. 
Today, cardiac transplantation is part of the normal array of procedures, and practically 
all children with cardiac defects can be treated.
Palliative vs. corrective surgery
Cardiac surgery aims for either correction of the defect or palliation of the symptoms. In 
a palliative operation, an additional cardiac anomaly is made to relieve the circulation 
(e.g. Blalock-Taussig shunt and pulmonary banding). 
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In a corrective operation the defect is repaired to obtain normal anatomy and physiology 
of the heart and circulation.  Corrective operations include closure of PDA, ASD and 
VSD, and repair of COA and TOF. An arterial switch for transposition of the great 
arteries (TGA) is certainly a corrective operation, both physically and anatomically. 
However, also the atrial switch (Mustard, Senning) is considered corrective because 
the physiology of the circulation is normalized, even the anatomy of the heart is far 
from normal after the procedure (Turina et al. 1992). 
All treatments available for univentricular heart (UVH) are palliative. Although the latest 
modifications of Fontan operation result in good functional status among children 
(Mitchell et al. 2006, Hosein et al. 2007), the heart still only has one chamber and 
circulation will often deteriorate in later years (Giardini et al. 2008).
Mortality and survival
Early mortality
Mortality is highest during the first few months after surgery. Early (operative) mortality 
is the first measure of success of an operation. It includes all deaths within 30 days of 
the surgery and varies widely by the severity of the defect and the complexity of the 
procedure. Also the experience of the surgical team and many other hospital-related 
factors directly affect the early results (Davies 2001).
The early mortality rates of the corrective operations for PDA and ASD have been 
reported to be very low, from 0 to 1% (Table 2) (Murphy et al. 1990, Morris et al. 1991). 
During the earlier era the mortality from VSD repair was 7–11% (Table 2) (Morris et 
al. 1991, Roos-Hesselink et al. 2004). In later years, early deaths also among VSD 
21
patients have become very rare; the early mortality after repair of isolated VSD is 
nowadays less than 2% (Tucker et al. 2007, EACTS 2008). 
The early results of corrective surgery for COA have varied from 3% to 16% (Cohen 
et al. 1989, Morris et al. 1991, Kappetein et al. 1994). As many infants need urgent 
surgery for COA, the early results are slightly worse than those patients with isolated 
shunt lesions. Both infancy and urgency are known risk factors for perioperative 
death (Chang et al. 2006). According to the congenital database of The European 
Association for Cardio-Thoracic Surgery, the 30-day mortality from COA operations is 
about 3% (EACTS 2008). 
The early mortality after corrective surgery of TOF has been published to be from 9% 
to 32% among patients operated on prior to 1990 (Rizzoli et al. 1990, Morris et al. 
1991, Murphy et al. 1993, Jonsson 1995, Nørgaard et al. 1999, Bacha et al. 2001). 
The variation is probably caused by differing defect severity, patient age, and expertise 
of the operating centre. The recent early mortality of TOF patients has steadily been 
less than 4% (EACTS 2008); even operative mortality of only 1%  has been reported 
(Alexiou et al. 2001).
Variation in the early results has also been wide after corrective surgery for patients 
with TGA, from 5% to 28% (Morris et al. 1991, Helbing et al. 1994, Myridakis et al. 
1994, Meijboom et al. 1996, Gelatt et al. 1997, Sarkar et al. 1999, Losay et al. 2001, 
Lange et al. 2007). The variation has been caused by differing severity of the TGA 
(simple vs. complex). In simple TGA, the only defect in the heart is the transposition. 
In complex TGA, other defects, most often VSD, also need to be treated. Comparison 
of the results is complicated further by the different correction techniques (Mustard, 
Senning, arterial switch). 
22
E
ra
 o
f 
op
er
at
io
n
A
ge
 a
t 
op
er
at
io
n 
(y
ea
rs
)
E
ar
ly
 
de
at
h 
(%
)
A
ct
ua
ri
al
 
su
rv
iv
al
, 
in
cl
ud
in
g 
ea
rl
y 
de
at
hs
A
ct
ua
ri
al
 s
ur
vi
va
l (
%
) a
ft
er
 s
ur
ge
ry
 (y
ea
rs
)
N
ot
e
D
ef
ec
t
S
tu
dy
5
10
15
20
25
30
35
P
at
en
t d
uc
tu
s 
ar
te
ri
os
us
M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
0
Y
E
S
99
98
98
96
96
op
er
at
io
n 
ag
e 
> 
3 
m
on
th
s
A
tr
ia
l s
ep
ta
l
M
ur
ph
y 
et
 a
l. 
19
90
19
56
–6
0
2–
62
3
Y
E
S
97
90
88
83
81
74
de
fe
ct
M
ur
ph
y 
et
 a
l. 
19
90
19
56
–6
0
2–
11
0
Y
E
S
N
A
N
A
N
A
N
A
97
si
m
ila
r t
o 
co
nt
ro
ls
M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
1
Y
E
S
99
98
98
96
92
Ve
nt
ri
cu
la
r
M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
7
Y
E
S
91
90
90
87
86
se
pt
al
 d
ef
ec
t
R
oo
s-
H
es
se
lin
k 
et
 a
l. 
20
04
19
68
–8
0
0–
13
11
Y
E
S
~8
8
~8
8
~8
6
~8
5
~8
5
~8
5
C
oa
rc
ta
tio
n 
of
C
oh
en
 e
t a
l. 
19
89
19
46
–8
1
0–
72
3
Y
E
S
94
91
~9
0
84
~7
8
72
ao
rt
a
C
oh
en
 e
t a
l. 
19
89
19
46
–8
1
0–
14
2
Y
E
S
~9
7
~9
6
~9
4
91
M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
6
Y
E
S
90
90
89
88
79
K
ap
pe
te
in
 e
t a
l. 
19
94
19
51
–8
5
0–
3
16
Y
E
S
~8
1
~8
1
~8
1
~8
1
~8
1
~8
1
Te
tr
al
og
y 
of
M
ur
ph
y 
et
 a
l. 
19
93
19
55
–6
0
0–
47
20
N
O
95
92
92
91
87
86
Fa
llo
t
M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
11
Y
E
S
86
86
86
84
82
Jo
ns
so
n 
19
95
19
66
–7
6
0–
54
15
Y
E
S
82
78
~7
5
72
R
iz
zo
li 
et
 a
l. 
19
90
19
75
–8
7
0–
50
9
Y
E
S
~8
7
84
84
K
no
tt-
C
ra
ig
 e
t a
l. 
19
98
19
71
–9
0
0–
25
N
A
N
O
98
98
98
98
M
iy
am
ur
a 
et
 a
l. 
19
93
19
65
–7
1
2–
28
N
A
N
O
~9
9
97
96
94
91
N
ør
ga
ar
d 
et
 a
l. 
19
99
19
60
–7
7
0–
41
32
N
O
~9
5
~9
5
~9
3
~9
2
~8
5
~8
5
~6
5
pr
im
ar
y 
re
pa
ir
N
ør
ga
ar
d 
et
 a
l. 
19
99
19
60
–7
7
0–
41
32
N
O
~9
8
~9
8
~9
6
~9
5
~9
4
~8
5
~8
5
1)
 s
hu
nt
, 2
)r
ep
ai
r
B
ac
ha
 e
t a
l. 
20
01
19
72
–7
7
0–
2
14
Y
E
S
86
86
86
86
A
le
xi
ou
 e
t a
l. 
20
01
19
74
–2
00
0
0–
1
1
Y
E
S
~9
8
~9
8
~9
8
~9
8
Ta
bl
e 
2.
 O
pe
ra
tiv
e 
m
or
ta
lit
y 
(e
ar
ly
 d
ea
th
) a
nd
 a
ct
ua
ria
l s
ur
vi
va
l a
fte
r c
or
re
ct
iv
e 
su
rg
er
y 
in
 s
tu
di
es
.
23
E
ra
 o
f 
op
er
at
io
n
A
ge
 a
t 
op
er
at
io
n 
(y
ea
rs
)
E
ar
ly
 
de
at
h 
(%
)
A
ct
ua
ri
al
 
su
rv
iv
al
, 
in
cl
ud
in
g 
ea
rl
y 
de
at
hs
A
ct
ua
ri
al
 s
ur
vi
va
l (
%
) a
ft
er
 s
ur
ge
ry
 (y
ea
rs
)
N
ot
e
D
ef
ec
t
S
tu
dy
5
10
15
20
25
30
35
Tr
an
sp
os
iti
on
 
of
 th
e 
gr
ea
t 
ar
te
ri
es
 (T
G
A
)
M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
22
Y
E
S
69
64
61
TG
A
, M
us
ta
rd
  M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
28
Y
E
S
~6
5
~6
0
~5
9
H
el
bi
ng
 e
t a
l. 
19
94
19
65
–7
7
0–
14
21
N
O
93
91
91
si
m
pl
e 
TG
A
 
H
el
bi
ng
 e
t a
l. 
19
94
19
65
–7
7
0–
14
N
A
N
O
76
60
60
co
m
pl
ex
 T
G
A
M
yr
id
ak
is
 e
t a
l. 
19
94
19
71
–8
1
0–
17
11
Y
E
S
86
86
86
86
si
m
pl
e 
TG
A
M
yr
id
ak
is
 e
t a
l. 
19
94
19
71
–8
1
0–
17
9
Y
E
S
87
77
64
64
co
m
pl
ex
 T
G
A
M
ei
jb
oo
m
 e
t a
l. 
19
96
19
73
–7
6
0–
2
6
Y
E
S
~8
0
~7
5
~7
0
M
ei
jb
oo
m
 e
t a
l. 
19
96
19
77
–8
0
0–
5
5
Y
E
S
~9
5
~9
4
G
el
at
t e
t a
l. 
19
97
19
63
–9
2
0–
19
10
N
O
89
88
82
76
74
S
ar
ka
r e
t a
l. 
19
99
19
65
–8
0
0–
5
9
N
O
86
82
77
La
ng
e 
et
 a
l. 
20
07
19
74
–8
2
0–
5
8
N
O
~9
4
~9
1
~8
5
~8
3
76
TG
A
, S
en
ni
ng
M
or
ris
 e
t a
l. 
19
91
19
58
–8
9
0–
18
10
Y
E
S
~8
8
~8
8
Tu
rin
a 
et
 a
l. 
19
92
19
65
–8
8
N
A
N
A
N
O
95
91
88
81
H
el
bi
ng
 e
t a
l. 
19
94
19
61
–8
7
0–
11
9
N
O
98
95
78
si
m
pl
e 
TG
A
H
el
bi
ng
 e
t a
l. 
19
94
19
61
–8
7
0–
11
N
A
N
O
84
79
79
co
m
pl
ex
 T
G
A
S
ar
ka
r e
t a
l. 
19
99
19
78
–9
2
0–
1
6
N
O
95
94
94
La
ng
e 
et
 a
l. 
20
07
19
77
–2
00
1
0–
2
5
N
O
~9
7
~9
6
~9
4
~9
3
91
TG
A
, a
rt
er
ia
l 
sw
itc
h
Lo
sa
y 
et
 a
l. 
20
01
19
82
–9
9
0–
0.
3
9
Y
E
S
88
88
88
U
ni
ve
nt
ri
cu
la
r 
Fo
nt
an
 e
t a
l. 
19
90
19
68
–8
8
N
A
8
Y
E
S
86
84
74
he
ar
t, 
Fo
nt
an
 
D
ris
co
ll 
et
 a
l. 
19
92
19
73
–8
4
1–
42
16
Y
E
S
70
60
pr
oc
ed
ur
e
M
itc
he
ll 
et
 a
l. 
20
06
19
92
–9
9
N
A
7
N
O
95
H
os
ei
n 
et
 a
l. 
20
07
19
88
–2
00
4
0–
52
4
Y
E
S
90
86
82
24
Early mortality from the Fontan operation, which palliates the UVH circulation, has been 
8–15% (Fontan et al. 1990, Driscoll et al. 1992). The results from Fontan procedure 
have also improved in later decades; early mortality has stabilized at 4–7% (Mitchell 
et al. 2006, Hosein et al. 2007, EACTS 2008). 
Late survival
In earlier published long-term follow-up studies, the population pools have often 
been selected (case mix). Most studies have dealt with solitary defects treated in one 
institution (Cohen et al. 1989, Murphy et al. 1990, Meijboom et al. 1993, Miyamura et 
al. 1993, Murphy et al. 1993, Meijboom et al. 1994, Myridakis et al. 1994, Meijboom et 
al. 1996). One large population-based study was conducted in Oregon, USA (Morris 
et al. 1991), but it excluded patients with palliative operations. Comparing results of 
different studies is almost impossible, as different diagnoses and case selections 
confound the findings. Moreover the era of the surgery, patients’ age and details of 
the heart defect and surgical technique have an effect on survival as seen in Table 2.
The late survival of patients after surgery varies according to the diagnosis. The late 
survival of PDA patients is lower than that in the general population (Morris et al. 
1991). The twofold death rate among PDA patients is due to pulmonary hypertension 
and comorbid conditions, such as non-cardiac malformations and complications of 
prematurity. According to survival rates ASD closure is a curative procedure; after 
successful operation, patients’ life expectancy is similar to that of the general population 
(Murphy et al. 1990, Morris et al. 1991).  
The 15-year survival after VSD closure is about 90%, and the mortality rate is fourfold 
that expected during the overall follow-up of 25 years (Morris et al. 1991). The 35-year 
survival has been reported to be 85% (Roos-Hesselink et al. 2004). 
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Among COA patients, the 15-year post-surgical survival has been in most studies over 
85% (Cohen et al. 1989, Morris et al. 1991, Kappetein et al. 1994), and the 25-year 
survival around 80% (Cohen et al. 1989, Morris et al. 1991, Kappetein et al. 1994). 
The expected number of deaths has been significantly lower than the actual number 
of deaths (Morris et al. 1991).
The 15-year survival after successful repair of TOF already exceeded 90% in the 
early era of surgery (Miyamura et al. 1993, Murphy et al. 1993, Knott-Craig et al. 
1998, Nørgaard et al. 1999). When the fairly high early mortality is included in the 
survival analysis, the 15- and 20-year survival rates decline to 75–86% and 72–84%, 
respectively (Rizzoli et al. 1990, Morris et al. 1991, Jonsson 1995, Bacha et al. 2001). 
In a recent study, mainly including patients operated on during 1980–2000, the 20-
year survival has been as high as 98% (Alexiou et al. 2001), probably similar to that of 
the general population. 
The atrial switch procedures for TGA patients have resulted in 15-year survival rates 
from 60% to 94% (Table 2) (Morris et al. 1991, Turina et al. 1992, Helbing et al. 1994, 
Myridakis et al. 1994, Meijboom et al. 1996, Gelatt et al. 1997, Sarkar et al. 1999, 
Lange et al. 2007). Comparison of the late results from different studies is challenging 
for the reasons mentioned in the early mortality section, and even more by variation 
in the analyses, specifically whether early deaths have been included or not. The 
atrial switch operation for TGA has fallen out of use. The treatment of choice is arterial 
switch. The late survival of arterial switch patients is better, and rhythm problems have 
almost disappeared with the change in the type of correction (Losay et al. 2001).
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Among selected UVH patients, the 15-year survival after the Fontan procedure has 
reported to be 74%, even in the earlier era of surgery (Fontan et al. 1990). Survival has 
improved nearly 10% in the later results (Hosein et al. 2007).
Cardiac morbidity and causes of late death
An operated heart is not a healthy heart. The morphology of the heart is usually 
slightly different from normal after surgical correction and definitely abnormal after 
palliation. Cardiac surgery often causes some sequelae. Scars in the heart muscle 
and connective tissue may interfere with contraction and give extra routes for electric 
impulses, enabling arrhythmias. The usage of artificial materials and even biomaterials 
causes an increased risk for endocarditis and reoperations. Heart failure, strokes 
and other cardiovascular diseases are also common, especially among patients with 
severe heart defects.
Operations per patient
The severity of the defects is also reflected in the number of operations and catheter 
procedures required after the primary operation. Patients with PDA or ASD rarely need 
more than one operation. Today, most of them do not need any surgical procedures, 
as their shunts are closed via a catheter (Schneider et al. 2006, Kharouf et al. 2008). 
An isolated VSD is most often corrected with a single operation (Lillehei et al. 1992, 
Roos-Hesselink et al. 2004).
Among COA patients, recoarctation and associated aortic valve disease often indicate 
reoperations (Cohen et al. 1989, Stewart et al. 1993, Kappetein et al. 1994). The 
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number of reoperations is decreasing because more and more recoarctations as well 
as primary coarctations are treated with catheter procedures (Horvath et al. 2008).
The number of reoperations needed after TOF repair varies markedly. In long-term 
follow-up studies, the reoperation rate has varied from 5% to 18% (Rizzoli et al. 1990, 
Miyamura et al. 1993, Murphy et al. 1993, Jonsson 1995, Knott-Craig et al. 1998, 
Nørgaard et al. 1999, Alexiou et al. 2001, Bacha et al. 2001). The main causes for 
reoperation have been pulmonary stenosis or regurgitation and reVSD.
Slightly over 10% of TGA patients with atrial switch (Senning or Mustard) have needed 
a reoperation (Turina et al. 1992, Myridakis et al. 1994, Meijboom et al. 1996, Gelatt et 
al. 1997, Sarkar et al. 1999, Lange et al. 2007). The main reason for the reoperations 
have been baffle complications. An even more common problem in these patients is 
arrhythmias; 10–14% have needed pacemakers (Myridakis et al. 1994, Meijboom et 
al. 1996, Gelatt et al. 1997, Lange et al. 2007). After arterial switch coronary blood 
flow problems and pulmonary stenosis have been reported to be the major problems 
(Losay et al. 2001, Legendre et al. 2003).
Patients with UVH are frequently operated on several times. They usually have been 
operated on at least once before the Fontan operation, and reoperations are often 
required (Fontan et al. 1990, Hosein et al. 2007). 
Cardiac medicines
Operated CHD patients fairly often have cardiovascular problems: arrhythmias, 
coronary heart disease, hypertension and heart failure. Most problems, arrhythmic and 
hemodynamic, resolve with surgery, catheter procedure or pacemaker implantation, 
but some patients also need cardiac medicines. 
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The prevalence of cardiovascular problems is described in earlier studies in detail, yet 
the pharmaceutical therapy used is hardly ever mentioned. Furthermore, the actual 
effectiveness of medicines (other than those used in hospital) is rarely studied in 
clinical trials of patients with CHD, both children and adults.
Causes of CHD-related deaths
Most CHD patients die due to the heart defect (Cohen et al. 1989, Lillehei et al. 1992, 
Meijboom et al. 1994, Gelatt et al. 1997, Nollert et al. 1997). The mechanism of death 
varies between defects and procedures performed (Oechslin et al. 2000). 
Heart failure is a common cause of death, especially among patients whose operation 
has been palliative, like UVH patients with Fontan circulation (Fontan et al. 1990). As 
the patients often need reoperations, one quite common cause of late cardiac death is 
a subsequent cardiac operation (Oechslin et al. 2000). 
Sudden death is also quite common among CHD patients. The risk of sudden death 
among patients with aortic stenosis, corrected TOF and TGA (after atrial switch) has 
been reported to be 50–200 times higher than that of the age- and sex-matched 
control population (Silka et al. 1998). The mechanism of sudden death among TOF 
and TGA patients is arrhythmias (Gatzoulis et al. 2000, Kammeraad et al. 2004, Sun 
et al. 2004).
Other cardiovascular problems also cause deaths among operated CHD patients. 
Patients with COA have been reported to be at high risk of death due to coronary 
heart disease and cerebrovascular accidents (Cohen et al. 1989). Coronary problems 
are also quite common among TGA patients who have been corrected with arterial 
switch (Legendre et al. 2003). Endocarditis is a rare but sometimes lethal disease 
among operated CHD patients (Morris et al. 1998). Especially patients with a valve 
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prothesis, aortic valve disease and cyanotic heart defect have increased risk for 
infective endocarditis (Horstkotte et al. 2004).
Comorbidity and causes of non-CHD-related deaths
Health problems often cluster. Patients with chronic diseases often have several of 
them and because of multiple diseases also a big burden of medicines (Reunanen 
et al. 2000, Ikäheimo et al. 2005). This may be partly caused by frequent visits to the 
doctor, during which even minor discomforts can be easily brought up, examined and 
treated. Moreover, a clear connection between chronic physical diseases and mental 
health problems, especially depression, has been described recently in the World 
Health Surveys (Moussavi et al. 2007).
Patients with CHD often have additional diseases. In a recently published study, the 
leading comorbid problems of CHD children were genetic syndromes and neurological 
and pulmonary diseases (Massin et al. 2007).  The most common genetic abnormalities 
causing CHD are Down’s syndrome and microdeletion of chromosome 22q11 (Hoffman 
1995, Meberg et al. 2007). 
CHD patients have an increased risk of being mentally retarded. Genetic syndromes 
or hypoxia due to cardiac defect or surgery can lead to mental retardation. Especially 
in the earlier days of cardiac surgery, cardiopulmonary bypass and related techniques, 
although enabling repair of the heart itself, were often not sufficiently gentle to avoid 
brain damage entirely. 
Mental retardation is the most severe form of neurological damage caused by cardiac 
defect or surgery. Milder damage manifesting as epilepsy and other neurological 
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diseases, is also quite common among CHD children (Massin et al. 2007). The 
neurodevelopment of children after open heart surgery is somewhat impaired (Hövels-
Gürich et al. 1997, Rappaport et al. 1998, Clancy et al. 2003). The neurological 
sequelae of surgery have led to great strides in brain monitoring and other techniques 
of brain protection (Williams et al. 2007).
Pulmonary diseases may be caused by the cardiac disease itself, but often the lung 
injuries are connected to cardiopulmonary bypass perfusion, blood transfusion and 
ventilation (Weissman 2004, Silliman et al. 2005, Groeneveld et al. 2007). Congestion 
of the lungs, whether caused by cardiac defect or surgery, has been associated with 
development of asthma (Matsuoka et al. 1994). 
The mental health of CHD patients can also be endangered. The burden of chronic 
illness has been shown to cause mental problems (Pless et al. 1989) and even to lead 
to suicide (Harris et al. 1994). Patients with CHD have expressed some anxiety and 
depression, but the problems have not been especially severe (Gupta et al. 1998, 
Popelova et al. 2001, Bromberg et al. 2003, van Rijen et al. 2004). Only singular 
suicides have been reported (Murphy et al. 1993, Nollert et al. 1997, Oechslin et al. 
2000).
Previous studies have reported that only a minority of patients have died due to non-
cardiac causes. The causes mentioned have been accidents, infections and other 
diseases (Cohen et al. 1989, Lillehei et al. 1992, Meijboom et al. 1994, Gelatt et al. 
1997, Nollert et al. 1997).
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Life after surgery
From the patients’ point of view, survival may not be the most important measure of 
therapeutic success. A long life burdened with disability and dissatisfaction can be of 
questionable value to a patient who, by survival criteria, represents a good outcome. 
A chronic disease has been reported to produce both negative and positive effects on 
the patient’s life (Pless et al. 1989, Lönnberg 1993, Kokkonen 1995). In many studies, 
good coping has resulted in an excellent quality of life, even for severely physically 
disabled patients (Lönnberg 1993). Documented positive effects have usually been 
related to education and employment (Utens et al. 1994), while difficulties in reaching 
independence and finding a partner have been the most common negative effects 
(Utens et al. 1994, Kokkonen 1995).
The overall health of patients of different diagnostic groups has been reported to be 
good (Horneffer et al. 1990, Gersony et al. 1993, Meijboom et al. 1994, Meijboom et al. 
1995). Furthermore, most operated patients have assessed their exercise tolerance 
to be similar to healthy persons or just slightly worse (NYHA classes I and II) (Cohen 
et al. 1989, Shampaine et al. 1989, Lillehei et al. 1992, Gersony et al. 1993, Jonsson 
1995, Nollert et al. 1997, Bacha et al. 2001). 
Patients with CHD value education and work (Utens et al. 1994, Horner et al. 2000). 
A high level of education has been reported frequently among patients with various 
defects (Lillehei et al. 1986, Lillehei et al. 1992, Gersony et al. 1993, Ternestedt et al. 
2001). However, contradictory results have also been reported. In a Dutch study, a 
surprisingly large proportion (27%) of CHD patients attended to special education, and 
the overall level of education was significantly lower than that of the control population 
(van Rijen et al. 2003).
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The patients have been described as “high achievers” at work (Brandhagen et al. 
1991). In a Dutch study, the patients proudly reported that they think they work harder 
and have been on sick leave less than their colleagues (Utens et al. 1994). This self-
assessment may, however, be groundless; CHD patients may overestimate their work 
intensity similarly to their exercise ability (Barber et al. 1991), and the number of sick 
leaves was proven to be underestimated by patients in one study (van Rijen et al. 
2003).
Although patients’ occupational status is good, they seem to have a low level of 
independence. Most patients have lived with their parents for a long time and seem to 
have problems in finding a partner and founding a family (Kokkonen et al. 1992, Utens 
et al. 1994). However, in more recent studies, the marital status and living conditions of 
CHD patients have been comparable with those of the normal population (Ternestedt 
et al. 2001, van Rijen et al. 2003). 
The patients have not had children as often as the general population (Gersony et al. 
1993, van Rijen et al. 2003). The fear of the heredity of the defect might be one reason 
for childlessness, even though the actual prevalence of CHD in patients’ offspring is 
quite low. The recurrence of a CHD varies widely between different defects. Patients 
with minor lesions have had children with CHD about three times more often than 
the expected 0.8–1% among the general population (Lillehei et al. 1992, Driscoll et 
al. 1993, Hoffman 1995, Zuber et al. 1999). Yet there has been no increase in the 
frequency of having children with CHD among patients with TOF and TGA (Miyamura 
et al. 1993, Clarkson et al. 1994, Jonsson 1995, Genoni et al. 1999, Zuber et al. 1999). 
Little knowledge exists about the heredity of UVH, as only a few patients have children.
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Cardiac follow-up
The frequent lack of adequate cardiac follow-up is a serious problem among this 
patient group (Gersony et al. 1993, Jonsson 1995, Meijboom et al. 1995).  The reason 
for the high rate of follow-up drop-outs is likely due to unsuccessful transfer of care 
from paediatric to adult hospitals. Some patients are more than willing to get rid of 
follow-up, with the transfer giving them an excellent chance to fade the disease away 
from their everyday life (Somerville 1997). The phenomenon is well known among all 
paediatricians treating adolescents with chronic diseases (Kolho et al. 2007). Once lost, 
the relation between patient and doctor maybe difficult to reunite, and this can postpone 
treatment unnecessarily. The interruption of follow-up may have fatal consequences 
(Somerville 1997). Lack of the special knowledge and resources needed to treat CHD 
adults is also a big problem throughout the Western world. This problem will only grow 
in the future. In the United States the estimated number of operated CHD adults was 
800 000 in 2000, meaning that 1 out of 350 young adults had a CHD. The prediction for 
the 2020s is that 1 out of 150 adults will have an operated CHD (Warnes et al. 2008). 
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AIMS OF THE STUDY
Aims of this study were to evaluate
1. the long-term survival of patients operated on for a congenital heart defect during 
childhood
2. the morbidity of CHD patients
3. the causes of late deaths of CHD patients
4. the life situation of CHD patients late after surgery
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METHODS
Number of patients and operations
The Research Registry of Paediatric Cardiac Surgery was established with permission 
of the Finnish Ministry of Social Affairs and Health in 1995. The long-term data collection 
began that year with the aim of producing a to database including all patients operated 
on during childhood for a congenital heart defect in Finland. Child was defined as a 
person less than 15 years of age at the time of the first cardiac operation.
The patients and procedures were collected from various data sets. The data of all 
operations conducted at five university hospitals (Helsinki, Turku, Tampere, Oulu and 
Kuopio) and in one district hospital (Aurora Hospital, Helsinki) were obtained. The 
diaries of the operation theatre, the diaries of the children’s ward and surgeons’ own 
records were used to find the operations. Once the procedures were found, the patient 
records were read to check the data of the diaries. 
The procedural data of years 1953–1989 covered the whole of Finland. The numbers 
of the 1990s and 2000–2007 included only patients operated on at Helsinki University 
Central Hospital. In the 1990s, about 1400 patients were operated on at other University 
Hospitals. Since 1998, all paediatric open-heart surgeries and all heart surgeries for 
neonates were centralized to Helsinki. Thus, the figures of the 21st century covered 
practically all of Finland. The only procedures missing from 2000–2007 were the 
closures of PDA in premature babies (about 400) and about 100 PDA closures and 
COA repairs for older children.
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Patients were given one primary diagnosis to facilitate comparison of survival between 
defects. Heart defects were sorted hierarchically (Table 3); patients with more than 
one defect were given the diagnosis highest on the list. For instance, a patient with 
COA, VSD and stenotic mitral valve was classified as VSD. The hierarchy was based 
on hierarchies published previously (Fyler 1980, Carlgren et al. 1987). 
Patients’ current status and address were obtained from the Finnish Population 
Registry. The date of death or emigration was also provided to us. The address was 
needed, since we aimed to find the patients last contact with secondary health care, 
which gave us the information about reoperations.
Univentricular heart
Hypoplastic left heart syndrome
Truncus arteriosus
Interrupted aortic arch
Transposition of great arteries
Atrioventricular septal defect
Total anomalous pulmonary venous drainage
Pulmonary atresia with intact ventricular septum
Tetralogy of Fallot
Ventricular septal defect
Coarctation of the aorta
Aortic stenosis
Pulmonary stenosis
Mitral valve disease
Partial anomalous pulmonary venous drainage
Atrial septal defect, secundum
Patent ductus arteriosus
Other
Table 3. Hierarchy of diagnosis.
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All data were stored in a computer running the custom-made research registry program 
ProCardio (Melba Group, Helsinki, Finland), based on FileMaker™ Pro 3.0 (Claris 
Corp, CA, USA). The current version of ProCardio is 8 and it runs under FileMaker™ 
Pro 8.5 (FileMaker Inc, CA, USA).
Mortality and survival (I, III)
The early mortalities (death within 30 days of first operation) of all patients and patients 
with PDA, ASD, COA, VSD, TOF, TGA and UVH were presented as percentages (I). 
Late mortality was assessed with survival analysis, which was done twice, excluding 
and including early deaths (I). Survival was calculated for all patients and separately 
for gender and diagnostic groups. The survival rate of patients operated on in different 
decades was also calculated separately to evaluate the progress of treatment (III). We 
compared the survival rates of different gender and decade groups, and analysed the 
survival with and without non-CHD-related causes of death. 
We compared each patient’s individual survival with that of the age-, sex- and time-
matched general population (I). For every patient and for every year of follow-up, we 
obtained the mortality of the general population. The expected probability of surviving 
a year was obtained for all individuals who, regardless of their survival status, were 
not censored prior to the beginning of the interval. We used the Hakulinen method 
(Hakulinen 1982) for combining the individual information with an estimate for the 
expected survival of the group.
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Cardiac morbidity (I, II) and causes of late deaths (III)
Operations per patients (I) and use of cardiac medicines (II)
Cardiac morbidity was assessed by the number of cardiac operations needed per 
patient and by usage of cardiac medications. The cardiac operations performed on 
patients after childhood were searched for from the hospital records. The usage of 
medications was investigated by linking the patients’ data from the Research Registry 
of Paediatric Cardiac Surgery to the data of the Social Insurance Institution’s registry 
of special reimbursement entitlements and medicine purchases.
The prevalence of chronic diseases was determined from the registry provided by the 
Finnish Social Insurance Institution. Individuals with certain specific chronic diseases 
(about 80 diseases) are entitled to special reimbursement for the drug treatment costs 
of that disease. To get the entitlement for special reimbursement (ESR), a patient 
applies for it from the Social Insurance Institution, and the application requires a 
certificate from a physician giving the details of diagnosis and disease treatment. The 
Social Insurance Institution centrally records the data of the ESRs. The four chronic 
cardiac diseases that entitle the patient to receive special reimbursement are heart 
failure, hypertension, arrhythmia and coronary heart disease.
The actual usage of medicines was determined from the medicine registry of the Social 
Insurance Institution. The medicine registry contains information on all details and costs 
of purchases of prescribed medicines. The records are based on on-line computerized 
information provided to the Social Insurance Institution by all Finnish pharmacies. In the 
registry, the medications are categorized by Anatomical Therapeutic Chemical (ATC) 
classification (WHO Collaborating Centre for Drug Statistics Methodology 2004). Use 
of a medication was defined as at least one purchase during 2004. 
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For each patient in our study population, two matched control subjects were chosen 
from the population registry. Matching criteria were sex, age (± 2 years) and hospital 
district in which the patient lived.
Causes of deaths (III)
The causes of late death were identified from death certificates obtained from Statistics 
Finland. If something unclear appeared on the death certificate, we examined the 
patient’s medical records. 
The causes were divided into CHD-related and non-CHD-related causes. CHD-related 
causes included deaths caused by diseases with ICD-10 (International Classification 
of Diseases) diagnosis numbers Q20 to Q28 (in older cases ICD-9 numbers 745 to 
747). All other causes were classified as non–CHD-related, also the rare cases of 
acquired heart disease. 
The causes of CHD-related deaths were evaluated further by dividing them according 
to an existing classification of the cardiac cause of deaths (Oechslin et al. 2000). 
The four classes of cardiac death were heart failure and sudden, perioperative and 
cardiovascular death. Sudden death was defined as death due to cardiovascular 
causes within 1 hour of onset (or significant worsening) of symptoms or unwitnessed 
death during sleep (Myerburg et al. 1992). The perioperative deaths included all early 
postoperative (within 30 days) deaths due to the patient’s second, third or fourth 
operation. The cardiovascular deaths included all CHD-related deaths that could not 
be classified into the other categories.
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Comorbidity and causes of non-CHD-related deaths (II, III)
Comorbidity was assessed by the usage of medications. The methods are described 
in detail under the heading Cardiac morbidity. Data of the causes of deaths were 
gathered as mentioned above (see Causes of deaths section).
The non-CHD-related causes of death of the patients were compared with the 
cause-specific mortality of the general population. The results appear as numbers 
of deaths observed and expected and as standardized mortality ratios (SMRs). SMR 
expresses the ratio of observed causes of death to that expected on the basis of 
overall mortality rates in the general Finnish population. The expected numbers of 
deaths were standardized for age, sex and time. The Poisson distribution was used to 
calculate the 95% confidence intervals. The significance of SMR was calculated using 
the approximation of Byar for the exact Poisson test (Breslow et al. 1987).
Life after surgery (IV)
Life situation of the patients was studied with a mailed questionnaire designed to elicit 
information about the patient’s general state of health, exercise tolerance, education, 
occupation, marital status, offspring and cardiac follow-up. The questionnaire was 
designed to be easy and quick to complete and unambiguous to interpret. 
Each operating hospital obtained permission to conduct this part of the study. They 
sent the inquiry to their own patients, and the results were combined. 
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The educational, employment and family statuses were compared with these of the 
general population, using data from the national statistical centre, Statistics Finland. 
The expected values with 95% confidence intervals were calculated as weighted 
averages of published age- and gender-specific rates. The calculations were carried 
out separately for each patient group. In the education section, patients under 20 
years of age were excluded. 
Statistical methods (I–IV)
The survival statistics were calculated with SURV3, the latest version of the survival 
analysis package developed at the Finnish Cancer Registry (Hakulinen et al. 1985). 
Relative risk (RR with 95% confidence intervals) analysis was used in evaluating 
the differences between the usage of medicines among patients and controls (II), 
and between observed and expected numbers of deaths (III). The differences were 
significant if the confidence intervals of RR did not include 1.0. 
Student’s unpaired t-test was used to compare the ages of patients and controls, and 
the ages of patients in different groups and statuses. The Chi-square test was used to 
compare frequencies between patients and the general population (II, IV).
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RESULTS
Number of patients and operations (I)
A total of 7240 cardiac operations were performed on 6461 children during the first 37 
years of cardiac surgery (1953–1989). The number of operations increased regardless 
of a concurrent decrease in the Finnish child population (Figure 2). 
The patients’ age at operation averaged 5.1 years (median 4.5; range 0–15). The 
mean age decreased during the study period from 8.9 to 3.4 years and the median 
even more, from 9.0 to 1.7 (Table 4). Since 1990, the age at operation declined further. 
In the Hospital for Children and Adolescents, the median age of operated children was 
less than one year (Table 4).
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Figure 2. Number of cardiac operations in Finland in 1953–1989. Bars are divided 
by patients’ age at operation. The continuous line represents the number of children 
(<15 years) of the whole population during the study years.
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The patient material varied over time, as more defects became surgically treatable. In 
the 1950s, most patients were operated on for PDA. During the subsequent decade, 
the number of operations and the variation in defects increased rapidly as open-heart 
surgery began. The number of patients with different defects operated on in different 
decades is presented in Table 5. The development continued. During the 21st century 
the proportions of patients with PDA and ASD diminished, while the proportion of 
miscellaneous defects rose (Table 5). The most common miscellaneous defects were 
atrioventricular septal defect (AVSD) and aortic stenosis during 1953–1989 and AVSD 
and hypoplastic left heart syndrome (HLHS) during 2000–2007.
Age, years Operative mortality
No. of 
operations mean median n %
1953–1959 329 8.9 9.0 11 3.3
1960–1969 1505 7.1 7.3 87 5.8
1970–1979 2337 5.5 5.3 193 8.3
1980–1989 3069 3.4 1.7 208 6.8
1953–1989 7240 5.1 4.5 499 6.9
1990–1999* 3131 2.3 0.7 218 7.0
2000–2003* 1138 2.0 0.4 50 4.4
2004–2007* 1173 2.1 0.5 27 2.3
* Procedures conducted at Helsinki University Hospital
Table 4. Age at operation and operative mortality.
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Mortality and survival (I, III)
Early mortality (I)
During the decades of the earlier era (1953–1989) the operative mortality varied from 
3.3% to 8.3%, with an overall average of 6.9% (Table 4). In the 1990s a slight rise 
occurred in early mortality, as increasingly complicated patients came into the reach 
of operative treatment. During 2000–2003 practically no defects were beyond the 
operative range. Thus, the operative mortality of 4.4% was excellent. In recent years, 
the operative mortality has decreased even more (Table 4).
When focusing on patients, the results looked slightly different. A total of 433 patients 
(7%) died within 30 days of their first operation (Table 5). The operative mortality was 
lowest (0–1%) in the ASD group throughout the years. The mortality increased as the 
defects became more complicated; in the UVH group, the operative mortality was 26% 
during the earlier era, and 8% (5/60) during 2000–2007 (Table 5). 
The strides in development of treatment were also seen in the operative mortality of 
HLHS: 1953–1989, it was an inoperable defect. When new techniques (e.g. Norwood 
operation) were taken into practice in the 1990s the operative mortality at Helsinki 
University Hospital was 60% (25/42). During 2000–2003 the early mortality was 23% 
(11/47), decreasing further in 2004–2007 to 5% (2/40). 
Late mortality (I, III)
A total of 592 patients out of the 6028 early survivors operated on during 1953–1989 
died late (>30 days) after surgery. The mortality was highest shortly after the first 
operation. During the first year 164 (28%) deaths occurred, almost half of them 
(n=79, 48%) during the first three months after surgery. The patients who died were 
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significantly younger at the time of their first operation than the patients who survived, 
3.9 (median 1.3, range 0–15) vs. 5.4 (median 5.1, range 0–15) years (p<0.001). The 
mean age of late death was 13.3 years (median 10.2, range 0.1–53). The patients died 
on average 9.4 years (median 5.8, range 0.08–39) after their first operation.
The cause of death was identified in 582 of the 592 patients (98%), and was confirmed 
with post-mortem examination in 474 cases (81%). Ten death certificates (2%) were 
unavailable, and thus, the cause of death was not determined. A total of 397 deaths 
(67%) were related, and 185 (31%) were unrelated to congenital heart defect. In most 
diagnostic groups, CHD-related causes of death dominated. Only patients with PDA 
and ASD died more often due to non-CHD-related causes (Figure 3).
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Figure 3. Proportions of causes of death. Numbers in blocks indicate the actual 
numbers of deaths in each diagnostic group. PDA=patent ductus arteriosus, 
COA=coarctation of aorta, ASD=atrial septal defect, VSD=ventricular septal defect, 
TOF=tetralogy of Fallot, TGA=transposition of the great arteries, UVH=univentricular 
heart, Misc=miscellaneous defects. 
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Late survival (I, III)
Compared with the general population (I)
The overall survival for 45 years was 78% for the patients and 93% for the general 
population. The average longevity of the patients was ten years shorter than that of the 
general population, 58 and 68 years, respectively. After excluding operative mortality 
patients’ survival increased to 84%, and the average longevity to 62 years. 
The negative effect of the disease gradually disappeared over the years and patients’ 
risk of death became similar to that of the control population. This was seen as planar 
or slightly rising curves of relative survival (Figure 4). With severe defects, the relative 
survival continued to decrease. The sharp drops of these curves were caused by the 
small numbers of living patients.
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Figure 4. Relative survival of patients and patient groups. Survival of the general 
population is 100%. Numbers beside the curves indicate the number of patients alive 
at 25, 36 (COA) and 38 (TOF) years post-surgery. Follow-up ended in October 1998.
PDA=patent ductus arteriosus, COA=coarctation of aorta, ASD=atrial septal defect, 
VSD=ventricular septal defect, TOF=tetralogy of Fallot, TGA=transposition of the 
great arteries, UVH=univentricular heart. 
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Late survival in different diagnostic groups in different decades (III)
The late survival rates of all patients operated on in 1953–1989 decreased decade 
after decade (Figure 5). This reflects that more children with severe congenital heart 
defects were treated during the later decades. In the 1960s, 1347 patients were 
operated on and most exhibited simpler defects than the 2418 patients operated on in 
the 1980s. 
The late survival of those patients with PDA who underwent surgery in the 1980s was 
significantly poorer than that during earlier decades (p<0.001). This result was due to 
the difference in the number of neonates undergoing surgery: 31% (186/601) in the 
1980s, and only 4% (22/498) in the 1970s. The difference in survival rates between 
decades in PDA patients disappeared when non-CHD-related causes were excluded 
from analysis (Figure 5), indicating that most of the neonates were small, premature 
babies dying from non-cardiac causes. The same effect of neonates was seen also 
in the analysis of all patients, because PDA was the biggest diagnostic group (23%, 
601/2602). 
As expected, the survival of patients with COA, ASD and VSD improved over the first 
decades of cardiac surgery in Finland (Figure 5). The late survival of patients with 
TOF who underwent surgery in the 1980s was worse than of those operated on in the 
1970s. The increase in mortality was mainly a result of patients in the 1980s being 
younger at the time of their operation (mean age 2.8 vs. 6.3 years, p<0.001). Also 
patients operated on in the 1980s the impact of age was significant. The mean age 
at operation for survivors was 3.0 years, and for those who died late after surgery 1.1 
years, p=0.015. The results of TOF patients seemed to get better during 1990–2003, 
even though the mean age at operation (0.9 years) was lower than during earlier 
decades. The 16-year survival was 96%, while during 1970s and 1980s it was 94% 
and 90%, respectively. However, these differences were not statistically significant.
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Figure 5. Survival of patients after their first operation excluding operative mortality. 
Division is by the decade in which the patient underwent the first surgery. The dotted 
green line in the figures for all patients and for patients with patent ductus arteriosus 
represents survival in the 1980s, when only CHD-related deaths were included in the 
analysis. Follow-up started from the patients’ first operation and ended in October 
1998.
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The survival of patients with TGA improved within time. The 15 year survival in 1970s 
was 72% and in 1980s 87%. The positive development of treatment continued during 
the later eras. The mid-term survival of the patients operated on for TGA during the 
1990s and at the beginning of the 21st century was better than earlier, as seen in 
Figure 6. 
The late survival of patients with UVH was quite poor. The 19-year survival for those 
operated on in the 1970s was better than for those operated on in the 1980s, 68% vs. 
55%. The higher mortality in the 1980s is explained by the complexity of the defects 
operated on. For example, during the 1980s, eight (14%) of the 56 operated UVH 
patients had a combination of UVH, TGA, and COA, whereas in the 1970s only one 
(3%) of the 33 patients had this complex defect. During the 1990s and in 2000–2003 
a trend towards better late survival of UVH patients emerged (Figure 6). However, the 
difference was not significant.
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Figure 6. Survival of patients with transposition of the great arteries and univentricular 
heart after their first operation excluding operative mortality. Division is by the decade 
in which the patient underwent the first surgery. Follow-up started from the patient’s 
first operation and ended in February 2007.
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Cardiac morbidity (I, II) and causes of late deaths (III)
Operations per patients (I) and use of cardiac medicines (II)
The studies of cardiac morbidity and causes of late deaths included all patients 
operated on during 1953–1989.
Many patients needed more than one surgical procedure to survive. Altogether 949 
patients were operated on several times; these comprised 16% of those 5774 who 
survived their first operation and had a complete follow-up. The number of operations 
needed varied according to the defect. PDA or ASD rarely required reoperation, 16% 
of patients with COA, every third VSD, TOF and TGA patient, and 80% of patients with 
UVH were operated on at least twice.
A total of 17% (855/5116) of patients and 8% (791/10232) of control subjects used 
medication for cardiac diseases, RR 2.16 (Cl 1.97–2.37). The patients using cardiac 
medicines were significantly younger than controls (mean age 38.2±0.4 vs. 44.9±0.4 
years, p<0.001). Patients using medication for cardiovascular diseases were older 
and had been operated on at an older age than the other CHD patients (mean age 
38.9±0.4 vs. 32.3±0.2 years, p<0.001, and mean age at first operation 6.4±0.2 vs. 
5.1±0.1 years, p<0.001).
The proportion of patients using cardiovascular medicines was high in all diagnostic 
groups, varying from 11% to 82% (Table 6). The proportion was highest among the 
patients with UVH. Of the patients with TGA, 37% used cardiac medicines. Most TGA 
patients (151/179, 84%) had had an atrial switch operation during childhood. 
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The cardiac diseases for which individuals can be granted an entitlement for special 
reimbursement (ESR) are heart failure, arrhythmia, hypertension and coronary 
disease. The number of patients with ESR for cardiovascular medicines was high in 
every heart defect group (Table 7).
 
Patients Controls
All Users % All Users % RR (95% Cl)
Patent ductus arteriosus 1759 229 13% 3518 392 11% 1.17 (1.00–1.36)
Coarctation of aorta 797 198 25% 1594 111 7% 3.57 (2.87–4.43)
Atrial septal defect 730 78 11% 1460 105 7% 1.49 (1.12–1.96)
Ventricular septal defect 617 66 11% 1234 51 4% 2.59 (1.82–3.68)
Tetralogy of Fallot 317 62 20% 634 41 6% 3.02 (2.09–4.38)
Transposion of the great 
arteries 179 66 37% 358 6 2% 22.00 (9.73–49.76)
Univentricular heart 45 37 82% 90 4 4% 18.50 (7.03–48.68)
Miscellaneous defects 672 119 18% 1344 81 6% 2.94 (2.25–3.84)
All 5116 855 17% 10232 791 8% 2.16 (1.97–2.37)
Table 6. Use of medicines for the cardiovascular system.
n Heart failure Arrhythmia Hypertension
Coronary heart 
disease
Patent ductus arteriosus 1759 40 2% 11 1% 85 5% 9 0.5%
Coarctation of aorta 797 79 10% 14 2% 122 15% 4 0.5%
Atrial septal defect 730 34 5% 21 3% 17 2% 1 0.1%
Ventricular septal defect 617 163 26% 16 3% 15 2% 0 0.0%
Tetralogy of Fallot 317 79 25% 20 6% 6 2% 1 0.3%
Transposion of the great 
arteries 179 95 53% 17 9% 2 1% 3 1.7%
Univentricular heart 45 37 82% 12 27% 1 2% 4 8.9%
Miscellaneous defects 672 165 25% 23 3% 25 4% 4 0.6%
All patients 5116 692 14% 134 3% 273 5% 26 0.5%
Table 7. Entitlements to special reimbursement for cardiac diseases
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A total of 692 patients (14%) had an ESR for medicines to treat heart failure. Five 
percent of patients had diagnosed hypertension. The majority of these were patients 
with COA. Altogether 15% of COA patients had an ESR for hypertension drugs (Table 
7). A further 134 (2%) patients had an ESR for medicines to treat arrhythmias. The 
proportion of patients having arrhythmias was largest among those with TOF, TGA 
and UVH (6%, 9% and 27%, respectively). Coronary heart disease was most common 
among patients with UVH (9%, 4/45) and TGA (2%, 3/179). None of the 16 patients 
with an arterial switch operation for TGA had medication for coronary artery disease.
The cardiac medicines most commonly used were beta-blocking agents (9%, 475/5116). 
The group of agents acting on the renin-angiotensin system was the second biggest, 
(7%, 376/5116). The differences between diagnostic groups are shown in Table 8.  The 
same cardiac medicines were also the most commonly used among control subjects 
(Table 8). The third biggest group of cardiac drugs used by controls was serum lipid 
reducing agents. This was the only group in which the proportion of users among 
patients and controls was similar (RR 1.12, Cl 0.90–1.39). 
The number of patients using antithrombotic agents was 228 (5%). The risk of having 
this medication was 8.44 (Cl 6.29–11.34) compared with controls. Most of the patients 
using the antithrombotic drugs had an artificial heart valve. 
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Cardiac causes of late death (III)
A total of 397 patients died late after their first operation owing to cardiac causes that 
were likely related to CHD.
Heart failure
Most CHD-related deaths resulted from heart failure (40%, 158/397), which was the 
main mechanism of death in the PDA, TGA and UVH groups (Figure 7). One-fourth 
(38/158) of the patients who died due to heart failure had been previously diagnosed 
with pulmonary hypertension. 
n
Mean 
age
 Cardiac 
glycosides Diuretics
Beta 
blocking 
agents
Calcium 
channel 
blockers
Agents 
acting 
on renin-
angiotensin 
system
Serum 
lipid 
reducing 
agents
PDA 1759 37.2 4 0% 50 3% 123 7% 33 2% 92 5% 51 3%
COA 797 32.9 11 1% 26 3% 115 14% 42 5% 110 14% 25 3%
ASD 730 34.7 4 1% 12 2% 47 6% 6 1% 28 4% 17 2%
VSD 617 28.8 11 2% 12 2% 39 6% 9 1% 26 4% 5 1%
TOF 317 32.1 11 3% 17 5% 36 11% 1 0% 17 5% 6 2%
TGA 179 23.9 30 17% 15 8% 28 16% 2 1% 46 26% 1 1%
UVH 45 24.8 15 33% 17 38% 22 49% 2 4% 11 24% 5 11%
Misc 672 31.0 26 4% 27 4% 65 10% 16 2% 46 7% 15 2%
All 5116 33.4 112 2% 176 3% 475 9% 111 2% 376 7% 125 2%
Controls 10232 33.4 2 0% 84 1% 384 4% 119 1% 308 3% 224 2%
Table 8. Use of cardiac medicines.
PDA=patent ductus arteriosus, COA=coarctation of aorta, ASD=atrial septal defect, 
VSD=ventricular septal defect, TOF=tetralogy of Fallot, TGA=transposition of the great arteries, 
UVH=univentricular heart, Misc=miscellaneous defects. 
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Operative deaths
A total of 104 (26%) late CHD-related deaths resulted from a second, third, or fourth 
heart operation. The majority of perioperative deaths (54, 52%) occurred early (within 
30 days) after the corrective operation among patients whose first operation had been 
palliative; 31 patients died early after reoperation, and 19 died early after palliative 
surgery. Surgery was the main mode of death among patients with TOF (20/60 deaths); 
11 died early after the corrective operation, 7 after reoperation and 2 after palliative 
operation.
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Figure 7. Number and proportion of modes of CHD-related deaths in different defect 
groups and in males and females, respectively. Perioperative = death within 30 days 
of 2nd, 3rd or 4th operation.
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Sudden deaths 
Of the CHD-related deaths, 88 (22%) occurred suddenly. The vast majority of these 
patients had undergone corrective surgery (61/88, 69%). In most cases, sudden death 
resulted from arrhythmia, as no other reason for death could be found in post-mortem 
examination (84%, 74/88 were examined). The majority of these patients also had 
arrhythmias in their medical history. In nine cases (10%), the death was known to be 
related to physical exercise. Seven of those patients were repaired (2 TOF, 2 TGA, 
2 VSD, COA) and two patients had unoperated valvular aortic stenosis (AS). The 
underlying causes of sudden death are presented in Table 9. 
Cause of sudden death n Cause of cardiovascular death n 
Arrhythmia / heart failure / 
unknown 73 Stroke 11
Rupture of aorta 5 Arrhythmia 6
Pulmonary emboli 3 Pulmonary emboli 6
Myocardial infarct 2 Endocarditis 4
Shunt occlusion 2 Brain abscess 4
Rupture of an aneurysm of 
main pulmonary artery 1 Thrombosis 4
Subarachnoidal bleeding 1 Myocardial infarct 3
Pulmonary haemorrhage 1 Rupture of an aneurysm of patent ductus arteriosus 2
All 88 Valve prothesis complication (aortic) 2
Pulmonary haemorrhage 2
Pericarditis 1
Myocarditis 1
All 46
Table 9. Causes of sudden and cardiovascular deaths.
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Sudden death was the most common mode of death among patients with COA (13/31, 
42%) (Figure 7). Of the COA patients who died suddenly five (38%) exhibited untreated 
AS. In four cases, the underlying cause was a ruptured or dissected aorta. 
Among patients with TOF (18/60) and TGA (19/63), 30% of CHD-related deaths were 
sudden. In these diagnotic groups, a gender difference existed in the incidence of 
sudden death; 6% (15/246) of male patients with TOF and 10% (17/171) of male 
patients with TGA died suddenly. The proportion of sudden deaths among female 
patients was 2% in both groups (3/168, 2/171, respectively). When TOF and TGA 
groups were combined and RR of sudden death between males and females was 
compared, males’ risk for sudden death appeared to be 3.9 (CI 1.5–9.9) times higher 
than that of females.
The only death caused by anti-coagulation therapy was also sudden; a patient with an 
operated COA and a prosthetic aortic valve died due to subarachnoidal bleeding. The 
patient’s treatment with warfarin was complicated by alcohol abuse. 
Other cardiovascular causes of deaths
Cardiovascular diseases related to congenital defects caused 46 deaths (12%). In this 
subgroup, three diseases dominated: stroke (n=11), arrhythmia (n=6), and pulmonary 
emboli (n=6) (Table 9). 
Endocarditis caused four deaths, accounting for 1% of all CHD-related deaths. The 
overall incidence of lethal endocarditis was 0.07% (4/6024). Two of these four patients 
had a bicuspid aortic valve, one exhibited recoarctation, and one patient with UVH 
failed to recover from the Fontan operation. 
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Three patients died due to myocardial infarct; one patient with operated AS suffered 
from severe familial hypercholesterolemia, one patient had anomalous coronary 
arteries (VSD+COA), and one patient (COA, AS and Turner’s syndrome) had an 
occluded coronary artery. In two cases, the myocardial infarction was classified as 
non-CHD-related: the first involved a 44-year-old patient with operated COA, severe 
diabetes with several complications, and a kidney transplant, and the second was a 
36-year-old patient with operated PDA. 
Comorbidity and causes of non-CHD-related deaths (II, III)
Patients had more chronic diseases than controls according to the number of ESRs 
for medicines, 30% (1550/5116) and 12% (1194/10232), respectively (RR 2.60, 2.43–
2.78). The five most common chronic diseases (including cardiac diseases) among 
patients were heart failure (14%), hypertension (5%), asthma (5%), arrhythmias (3%) 
and epilepsy (3%). The controls most often had asthma (3%) and hypertension (3%). 
In all other diseases, the proportion of controls with the disease was less than 2%. 
Only six of the 20 most common diseases (diabetes, rheumatoid arthritis, inflammatory 
bowel diseases, coronary heart disease, severe dermatitis and breast cancer) had the 
same prevalence within patient and control population (Table 10).
The health problems clustered. Altogether 26% (397/1550) of CHD patients and 
19% (228/1194) of controls had more than one ESR.  Even after omitting all cardiac 
diseases, 20% (110/540) of the CHD patients had more than one chronic disease 
according to ESRs. 
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Disease
Patients     
(n=5116)
Controls 
(n=10232) RR (95% Cl)     
1.Heart failure 692 13.5% 12 0.1% 115.3 (65.2–203.9)
2.Hypertension 273 5.3% 257 2.5% 2.12 (1.80–2.51)
3.Asthma 248 4.8% 283 2.8% 1.75 (1.48–2.07)
4.Arrhythmias 134 2.6% 17 0.2% 15.76 (9.53–26.1)
5.Epilepsy 133 2.6% 110 1.1% 2.42 (1.88–3.11)
6.Psychoses 97 1.9% 115 1.1% 1.69 (1.29–2.21)
7.Hypothyroidism 78 1.5% 116 1.1% 1.34 (1.01–1.79)
8.Diabetes 57 1.1% 140 1.4% 0.81 (0.60–1.11)
9.Rheumatoid arthritis 56 1.1% 102 1.0% 1.10 (0.79–1.52)
10.Hypogonadism 43 0.8% 19 0.2% 4.53 (2.64–7.76)
11.Anxiety disorders associated with 
mental retardation 29 0.6% 17 0.2% 3.41 (1.88–6.20)
12.Inflammatory bowel diseases 26 0.5% 60 0.6% 0.87 (0.55–1.37)
13.Coronary heart disease 26 0.5% 34 0.3% 1.53 (0.92–2.55)
14.Glaucoma 23 0.4% 12 0.1% 3.83 (1.91–7.70)
15.Status post-transplantation 16 0.3% 5 0.0% 6.40 (2.35–17.5)
16.Severe dermatitis (tacrolimus 
ointment) 11 0.2% 18 0.2% 1.22 (0.58–2.59)
17.Hypopituitarism 11 0.2% 1 0.0% 22.00 (2.84–170.4)
18.Breast cancer 8 0.2% 24 0.2% 0.67 (0.30–1.48)
19.Gout 8 0.2% 4 0.0% 4.00 (1.21–13.3)
20.Hypoparathyroidism 7 0.1% 0 0.0% –––
Table 10. Prevalence of chronic diseases according to special drug reimbursement 
records.
Furthermore, a chronic disease increased the risk of depression, which was not 
included in the diseases for which ESRs were granted. Of the CHD patients, 11% 
(163/1550) of those with an ESR and 6% (228/3566) of those without an ESR used 
antidepressants; among controls, these proportions were 14% (173/1194) and 5% 
(462/9038), respectively. The RR for using antidepressants and having a chronic 
disease with an ESR was 1.65 (CI 1.36–1.99) among CHD patients and 2.84 (CI 
2.41–3.34) among controls.
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The actual usage of medicines of patients was somewhat higher than that of controls. 
A total of 62% (3185/5116) of the patients had bought at least one prescribed medicine 
compared with 53% (5462/10323) of controls (RR 1.16 (Cl 1.13–1.20)). The overall 
usage of medicines was higher in patients than in controls in all diagnostic groups 
except ASD. 
Patients’ risk of death was twice as high as in the general population even if only the 
non-cardiac causes of death were concerned. Patients died more often than expected 
due to respiratory and neurological diseases, and less often than expected due to 
accidents (Table 11). 
Genetic abnormalities and mental retardation
Patients had more genetic abnormalities than the general population. For instance, the 
prevalence of Down’s syndrome in Finland was about 0.06% (Käypä Hoito -toimitus 
2004), whereas among CHD patients it was 2.3% (151/6460).
Altogether 280 patients (4.3%) operated on during 1953–1989 were known to have 
mental retardation, and 198 were still alive in October 2004. The expected number 
of patients with low IQ, calculated based on Finnish epidemiological study (Arvio 
et al. 2003), was less than 30. Most patients with mental retardation had a genetic 
syndrome. However, some patients were neurologically damaged by hypoxia due to 
the cardiac defect itself or the cardiac surgery. Among the patients operated on during 
the 1990s, the proportion of those mentally retarded was much higher than during the 
earlier era: 11% (209/1911) vs. 4.3%.
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All deaths (n=185)
observed expected SMR (95% Cl) p
Diseases 127 111 1.15 (0.96–1.15)
Infectious diseases 1 3 0.35 (0.01–1.96)
Neoplasms 18 19 0.93 (0.55–1.47)
Endocrine, nutritional, and metabolic 
diseases 5 4 1.38 (0.45–3.22)
Diseases of the nervous system 14 6 2.24 (1.22–3.75) 0.01
Diseases of the circulatory system 11 12 0.92 (0.46–1.66)
Diseases of the respiratory system 17 5 3.70 (2.16–5.93) <0.001
Diseases of the digestive system 3 2 1.44 (0.30–4.19)
Diseases of the genitourinary 
system 1 1 0.91 (0.02–5.07)
Congenital malformations and 
chromosomal abnormalities 22 23 0.95 (0.60–1.44)
Other diseases 27 30 0.91 (0.60–1.32)
Unknown 5 2 1.94 (0.63–4.54)
Alcohol-related diseases 3 4 0.80 (0.16–2.33)
Accidents and violence 58 74 0.78 (0.59–1.01)
Accidents 28 44 0.64 (0.42–0.92) 0.01
Suicides 23 23 0.98 (0.62–1.47)
Homicides 4 4 0.98 (0.27–2.51)
Unknown 3 3 1.30 (0.27–3.80)
Other 0 0 0.00 (0.00–18.44)
Table 11. Observed and expected causes of deaths unrelated to congenital heart 
defect. SMR = standardized mortality ratio with 95% confidence limits.
Neurological diseases
The most common neurological disease among CHD patients was epilepsy. Patients 
often used medicines for it, and six patients died due to epilepsy. Altogether 14 patients 
died due to neurological diseases. The number was over twice as high as among the 
general population (SMR 2.24, Cl 1.22–3.75) (Table 11).
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Among living patients, the risk of epilepsy was at the same level (RR 2.42, CI 1.88–
3.11). Altogether 133 patients (2.6%) had epilepsy. Of these 17% (n=23) were operated 
on as neonates (RR to other patients 2.87, CI 1.85–4.43). No difference was present in 
the prevalence of epilepsy between PDA and other neonatal patients. After exclusion 
of  patients operated on as neonates, the risk of epilepsy remained 2.12 (CI 1.62–2.76) 
times higher than that of the control population. Open-heart surgery did not increase 
the risk for epilepsy. 
Over one-fourth (26%, 34/133) of the patients with epilepsy were mentally retarded. 
However, even after exclusion of retarded patients, the number of CHD patients with 
epilepsy was significantly higher than that of controls (RR 1.80, CI 1.37–2.36)
Respiratory diseases 
The most common chronic respiratory disease among both patients and controls was 
asthma. Altogether 2.8% of controls had an ESR for medication to treat the condition. 
Nevertheless, cardiac patients had almost twice as high a risk for having asthma (RR 
1.75, CI 1.48–2.07) (Table 10). Of patients with asthma, 10% (26/248) were operated on 
before the age of one month (RR 1.61, CI 1.08–2.37, compared with patients operated 
on later). Among neonatally operated patients, the risk for asthma was highest among 
those with PDA (16/139, 12%), compared with those with other heart defects (10/212, 
5%) (RR 2.46, CI 1.15–5.27). However, even after exclusion of all neonatally operated 
patients, the risk of asthma was 1.65 (CI 1.38–1.96) times higher than that among 
the control population. Cardiopulmonary bypass surgery, as compared with closed 
surgery, did not increase a patient’s risk of having asthma.
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Respiratory diseases caused the death of 17 patients. The SMR was 3.70 and the 
difference between patients and the general population was significant (p<0.001) 
(Table 11). Even though asthma was common among patients, only one of the deaths 
could be attributed to it. Most respiratory deaths resulted from pneumonia; six of these 
patients were mentally retarded and five were infants.
Psychiatric disorders 
Altogether 506 patients (9.9%) and 769 controls (7.5%) used medicines for psychiatric 
diseases (RR 1.32, CI 1.18–1.46) (excluding persons using only sleeping pills). The 
vast majority - 391 patients (7.6%) and 635 controls (6.2%) (RR 1.23, CI 1.09–1.39) 
- used antidepressants. Patients’ risk of using antidepressants did not differ between 
defect groups.
The number of suicides among patients was, despite the somewhat higher prevalence 
of depression, similar to the expected number (Table 11). All 23 patients who committed 
suicide had undergone corrective surgery. The patients had undergone surgery at 
least five (mean 16.8) years before death (9 PDA, 3 CoA, 3 pulmonary stenosis (PS), 
4 VSD, 3 ASD, 1 TOF). Two suicides were connected to heart defects; one ASD patient 
exhibited severe arrhythmias resistant to treatment, and the other patient who had 
pulmonary stenosis, committed suicide rather than agree to a reoperation.
Patients’ risk of having psychosis was 1.69 (CI 1.29–2.21) times higher than that 
of controls; 1.9% (n=97) of patients and 1.1% (n=115) of controls had an ESR for 
antipsychotics. The prevalence of psychosis was similar between defect groups.
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Use of antibiotics
The medicines most used were antibiotics; 30% of patients and 26% of controls (RR 
1.2, CI 1.11–1.23) had purchased anti-infective medicine at least once during 2004. 
Patients had bought 2789 courses of antibiotics (0.55 per patient), and controls 4314 
(0.42 per patient). 
Life after surgery (IV)
At the time of the life situation study (October 1998), 3789 adult patients operated on 
for congenital heart defect during childhood lived in Finland. A total of 2896 (76%) of 
them completed and returned the life situation questionnaire. Women answered the 
inquiry more often than men, 80% vs. 72% (p<0.001). The number of replies received 
from patients in each diagnostic group varied from 72% to 82%, being highest among 
patients with VSD. 
General health and exercise capacity
Most patients (2227/2896, 77%) described their general health as good. One-fifth 
(611, 22%) classified their health as moderately good and only 36 (1%) described 
their condition poor. In most cases, poor health was due to a condition unrelated to 
the cardiac defect or its treatment. Surprisingly, no patients with UVH (n=22) or TGA 
(n=64) reported poor health. By contrast five of the 1066 patients with PDA reported 
having a poor physical condition because of their heart defect.
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Most patients assessed their exercise tolerance as good. A vast majority, 97% 
(2320/2896), was classified into NYHA I and II, and 68 patients (2%) were in NYHA III. 
Only seven patients were symptomatic at rest (NYHA IV). The distribution was similar 
between diagnostic groups, except for the TOF (n = 180) and UVH groups. There were 
15 patients (8%) with TOF and five patients (23%) with UVH in NYHA class III; one 
patient from the TOF group and one from the UVH group were classified as NYHA IV.
Education and employment
The educational profile of patients was comparable with that of the general population. 
Most of the patients (2100/2676, 79%) had more than compulsory education, and 10% 
(257/2676) had a university degree. The level of education was significantly different 
from the expected in three patient groups. The number of COA patients with a vocational 
or university degree (356/420, 85%) was 6% higher than expected (p=0.003). On the 
other hand, in the ASD group, more patients than expected had compulsory education 
only, 24% (101/421) vs. 21% (p=0.038). Third difference to the expected level was 
found among patients with TOF, TGA and UVH; 3% had achieved a university degree, 
while the expected level was 7% (p=0.014).
The employment rate was higher among the patients than among the general 
population (70% vs. 66%; p<0.001, Table 12). Patients with PDA and COA (n=456) 
were employed significantly more often than their reference populations: 77% vs. 69% 
and 74% vs. 66%, respectively (p<0.001). As seen in Table 12, patients with TOF, TGA 
and UVH were employed less often than expected. The difference disappeared when 
patients with mental retardation (12 TOF and 1 TGA) were excluded. 
The overall unemployment rate of only 6% among patients contrasted with the 
expected rate, which was nearly twice as high (11%, p<0.001). The proportion of 
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students was similar to that in the general population. The observed retirement rate 
was 7%, while the expected rate was 3%. The most common reason for retirement 
was mental retardation, affecting 66 patients. Only 38 of the 207 retired patients were 
clearly disabled because of their heart defect. 
All patients
Observed (95% Cl) Exp p
Employed 2032 70% (69–72%) 66% <0.001
Unemployed 153 6% (4–6%) 11% <0.001
Students 375 13% (12–14%) 13%
Retired 207 7% (6–8%) 3% <0.001
Other* 114 4% (3–5%) 7% <0.001
TOF, TGA and UVH
Observed (95% Cl) Exp p
Employed 146 55% (49–61%) 61%
Unemployed 16 6% (3–9%) 10% 0.039
Students 50 19% (14–23%) 18%
Retired 43 16% (12–21%) 2% <0.001
Other* 11 4% (2–7%) 9% 0.014
* housewives, military service, etc.
Table 12. Working status of all adult patients and separately for those with tetralogy 
of Fallot, transposition of the great arteries and univentricular heart (TOF, TGA and 
UVH). The proportions were compared with expected levels (Exp).
Family life
The number of patients married was comparable with that for the general population. A 
total of 1043 patients (36%) were married, women more often than men, 40% and 30%, 
respectively (p<0.001). The proportion of patients who were unmarried, but living with 
a partner was greater than expected, 23% vs. 20% (p<0.001). However, there were 
also more single patients than expected, 37% vs. 35% (p=0.048). The concurrency 
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Having offspring
patients (95% Cl) exp p
Women 1708 908 53% (51–56%) 56% 0.022
Men 1188 441 37% (34–40%) 40% 0.038
All 2896 1349 47% (45–48%) 49% 0.002
Number of offspring
all with CHD (95% Cl) p
Women 1824 49 2.7% (2.0–3.5%) <0.001
Men 873 14 1.6% (0.8–2.4%) 0.029
All 2697 63 2.3% (1.8–2.9%) <0.001
Table 13. Number of patients having offspring. Proportion of patients relative to 
expected rates (exp). Expected rate of offspring with congenital heart disease (CHD) 
was considered to be 1%.
of a high number of patients living in a relationship and a high number of singles was 
possible, because the divorce rate among the patients was lower (4%, 105 patients) 
than the expected 7% (p<0.001).  No significant difference existed in the marital status 
between the TOF, TGA and UVH patients and the general population, except for the 
low divorce rate of patients (1% vs. 5%, p<0.01). 
Patients had become parents less often than expected. The difference was similar for 
both genders (Table 13). The number of children in a family was comparable with that 
of the general population, except that there were only 45 female patients, who had 
four or more children. The difference to the expected 67 was statistically significant 
(p=0.006). The number of parents with CHD was low regardless of the severity of the 
defect, yet the difference was biggest among those women who had TOF, TGA and 
UVH (35% vs. expected 46%, p=0.008). 
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The incidence of CHD among the offspring of patients was 2.4 times that of the general 
incidence of approximately 1% (Hoffman 1995). Of the 2697 children of the patients, 
64 (2.4%) had a heart disease. The incidence of CHD in offspring was 2.7% for women 
and 1.6% for men (p<0.001). 
Follow-up
Only 26% (742) of the adult patients were in planned and regular cardiac follow-up. 
After exclusion of patients with PDA (n=1066) and ASD (n=456), 53% (724/1374) of 
patients remained without follow-up. The only patient group where all patients had 
regular appointments was UVH. Several patients with a known high residual risk, e.g. 
36% (65/180) of TOF and 60% (274/456) of COA patients, and even two patients after 
a Mustard operation for TGA, were not followed up regularly. 
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DISCUSSION
Methods
This study offers unique results of the first 37 (1953–1989) years of paediatric cardiac 
surgery, with excellent coverage of the entire population of Finland, and gives also an 
overview of the surgical results of the 1990s and 2000–2007. 
With good cooperation between hospitals, we were able to trace all operations performed 
in the country. The highly accurate and comprehensive national population registry 
enabled a practically complete (96%) follow-up of these patients. The comparison of 
survival with that of the general population was possible, as the population register 
publishes reliable life-tables. Although most of the patients were still alive, calculation 
of longevity could be reliably made since the negative effect of the defect on mortality 
vanishes in the largest diagnostic groups decades after the operation.
The records of all patients were not read thoroughly and some details, such as 
syndromes, were left out. Yet as we searched for the patients’ last visit to a doctor, the 
overall situation of the living patients was fairly well defined. For deceased patients, 
some knowledge was probably lost, as most archives no longer retained the patients’ 
records 10–20 years after the death. 
The medicinal registries are very reliable, as the pharmacies gather and transfer the 
data on-line to the Social Insurance Institution. Unfortunately, data regarding indications 
for prescriptions and usage of prescription-free medications were unavailable. 
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In the life situation study, we wished to map the everyday life of thousands of patients. 
The health-related quality of life questionnaires were somewhat complicated for this 
purpose. Thus, we decided to design our own short and simple questionnaire, which 
addressed only the basic elements of life: health, fitness, education, employment and 
family. 
The life situation of patients was compared with that of the general population, which 
is recognized as the most relevant control group (Gledhill et al. 2000). In other studies, 
even the survival of voluntary age- and sex-matched controls proved to be better 
than that of the general population (Sihvonen et al. 2004). Thus, the life situation of 
voluntary controls would likely have most been too positive for a reliable comparison.
The most important and unavoidable bias of a mailed questionnaire study is always 
the inability to define all of the differences between patients who responded and those 
who did not. Another important bias in our study was that the results were based 
solely on patients’ self-reported conditions. This could cause slightly over-estimated 
values towards the awaited “good results”. For example, if the patient was retired 
and a student at the same time, it was more likely that the answer to the employment 
question would have been student rather than retired.
Number of patients and operations
The rising number of patients reflected well the progress of treatment. During the later 
years the number of operations levelled. At the beginning of the 21st century, more 
and more defects were cured with interventional catheter techniques. However, the 
number of operations did not decrease because patients with complicated defects 
needed many reoperations, both planned and unplanned.
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Mortality and survival
Early mortality
The operative mortality and the variation in defects treated reflect the progress of the 
whole chain of diagnosis and treatment. The early mortality increased 2.5-fold during 
the first three decades of surgery, as more complicated defects came into the reach 
of surgery. In the 1980s the operative mortality decreased to 6.8%, as experience 
was gained in the treatment of patients with the most common severe defects. The 
operative mortality of less than 3% during 2004–2007 represented an excellent 
international level (Welke et al. 2006, EACTS 2008). 
Naturally, the operative mortality differed by defects. During 1953–1989 altogether 
1–8% of PDA, ASD, VSD and COA patients died within the first month of their first 
operation. The proportion compares well with previously published mortality rates 
of that era: 0–13% (Table 2) (Cohen et al. 1989, Murphy et al. 1990, Morris et al. 
1991, Lillehei et al. 1992, Meijboom et al. 1993, Stewart et al. 1993, Meijboom et al. 
1994). During 2000–2007 the mortality of ASD, VSD and COA decreased further, and 
the early results in these groups were good and comparable with international levels 
(Tucker et al. 2007, EACTS 2008). In PDA, the mortality rate reached 10% during the 
present era. None of the deaths were associated with cardiac reasons; all patients 
died due to complications of prematurity. 
In TOF and TGA, the comparison of the early mortality with other studies among the 
1953–1989 material was almost impossible since all other published materials only 
included patients who underwent corrective operations (Rizzoli et al. 1990, Morris et 
al. 1991, Miyamura et al. 1993, Murphy et al. 1993, Helbing et al. 1994, Myridakis et 
al. 1994, Jonsson 1995, Knott-Craig et al. 1998). During the 21st century the numbers 
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of early deaths of patients with TOF, TGA and also UVH were comparable or even 
smaller than those in other studies (Dipardino et al. 2004, Welke et al. 2006, EACTS 
2008).
Survival
The survival of patients after surgery was lower than that of general population, but 
definitely better than the expected natural survival (Figure 8).
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Figure 8. Actuarial survival of patients and patient groups compared with general 
population and the natural survival of patients with atrial septal defect (ASD), coarctation 
of aorta (COA), tetralogy of Fallot (TOF) and univentricular heart (UVH) (Kirklin et al. 
1993a). Follow-up ended in October 1998.
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Previously published long-term results were not readily comparable with ours 
because our study included all defects and procedures. Developments in the practice 
of cardiology and cardiac surgery confounded comparisons even more. The overall 
survival in different diagnostic groups in our material was quite similar to previously 
published data (Table 2) (Cohen et al. 1989, Murphy et al. 1990, Morris et al. 1991, 
Lillehei et al. 1992, Turina et al. 1992, Meijboom et al. 1993, Miyamura et al. 1993, 
Murphy et al. 1993, Stewart et al. 1993, Helbing et al. 1994, Knott-Craig et al. 1998, 
Nørgaard et al. 1999, Sarkar et al. 1999, Alexiou et al. 2001, Losay et al. 2001).
In most diagnostic groups, the long-term results improved every decade. However, 
in some groups, the survival was worse in patients operated on in the 1980s. The 
lower survival rate was caused by more complicated defects and younger age at the 
time of surgery, both of which are known to be risk factors for mortality (Chang et al. 
2006). The complexity of the diseases will impact the results also in the future, but 
the negative effect of age at operation decreased already in the 1990s (Alexiou et al. 
2001, Losay et al. 2001). The future will show whether the improved early survival of 
infants in the current era will also lead to better late survival.
Cardiac morbidity and causes of late deaths
The severity of the defects operated on was also seen in the number of patients 
needing multiple operations. Patients with PDA or ASD rarely underwent more than 
one operation. In earlier studies, recoarctation and associated aortic valve disease 
indicated reoperations among COA patients (Cohen et al. 1989, Stewart et al. 1993, 
Kappetein et al. 1994). These problems caused the fairly high operation per patient 
rate also in this material. Most Finnish patients operated on for TOF in 1953–1989 
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were first palliated and then corrected. Thus, the patients needed more operations 
than in previous reports (Nollert et al. 1997, Nørgaard et al. 1999, Bacha et al. 2001). 
The subsequent corrective operations also caused relatively many late perioperative 
deaths. VSD and TGA patients’ need for several operations in this study was partly 
due to associated COA. Most of the UVH patients required more than one operation. 
Nowadays, all UVH patients are systematically operated on 2–3 times.
Astonishingly, 83% of patients did not need any cardiac medication late after surgery. 
Even 62% of the patients with an atrial switch did not use cardiac medication. However, 
as expected, the patients used more cardiovascular medicines than controls. The 
patients needing cardiac medication were older than other CHD patients. 
Age at operation had a clear effect on the cardiac symptoms needing medication; 
the higher the age at operation, the more cardiac sequelae appeared. Our findings 
indicate that patients should be operated on early, although in neonates very early 
operations should be done only in urgent cases, as neurological and pulmonary 
damage is common.
One-fifth of patients had an entitlement for special reimbursement (ESR) for cardiac 
medicines. The cardiac diseases of patients who were granted ESRs, comprised heart 
failure, arrhythmias, hypertension and coronary heart disease. They all also caused 
late mortality. Heart failure was the most common mode of CHD-related death. Most 
patients with lethal heart failure had diagnosed pulmonary hypertension. Part of the 
late mortality related to high pulmonary pressure could possibly have been avoided 
with more careful follow-up and earlier reinterventions, thus preventing the further rise 
of pulmonary resistance. 
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Arrhythmias were most common among patients with corrected TOF, TGA with atrial 
correction and UVH, all known to have a high prevalence of arrhythmias (Kirjavainen 
et al. 1999, Gatzoulis et al. 2000, Saliba et al. 2001, Warnes 2006). As in earlier 
studies, most sudden deaths in our patient material were attributed to arrhythmia and 
occurred most often in older patients with corrected heart defects (COA, TOF, TGA). 
In a previous study, 80% of near fatal arrhythmias and sudden deaths of the patients 
with TGA (atrial repair) occurred during exercise (Kammeraad et al. 2004). Among all 
of our patients, the number of sudden deaths that could be related directly to exercise 
was only 10%. The underlying circumstances of sudden deaths warrant comprehensive 
studies before any further recommendations for exercise can be given to the patients 
with CHD.
The fairly high risk of sudden death among COA patients, whose overall survival over 
a 30-year period exceeded 90%, was of concern. Health care professionals should 
ensure careful follow-up and treatment of these patients. As previously stated: The 
survivors of COA repair are "fixed", not cured (Celermajer et al. 2002).
Surprisingly, we discovered that male patients with corrected TOF and TGA died 
suddenly more often than females. The number of sudden deaths was small, and the 
significance of the difference was weak, but nevertheless it existed. When the two 
diagnostic groups were combined, the significance of the difference strengthened. 
Gender may be one of the factors that contribute to sudden death in CHD. Similar 
gender differences have been published among adults with other than morphological 
heart diseases. For instance, male patients with coronary heart disease and male 
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athletes die suddenly more often than do females (Maron et al. 1996, Abildstrom et al. 
2002). In addition, the types of arrhythmias differ between men and women (Wolbrette 
et al. 2002). The causes of these gender differences should be examined further.
The risk of hypertension was equal among patients and controls with the exception of 
COA patients. The 15% prevalence of hypertension among COA patients operated on 
as children was approximately the same as in the previously published data (Cohen et 
al. 1989, Høimyr et al. 2007). Those studies revealed that the number of patients with 
hypertension was much higher if the operation was performed after the patient’s 15th 
birthday. This indicates that COA should be corrected as soon as possible, while also 
bearing in mind the vulnerability of the neonatal brain and lungs, and the increased 
risk for recoarctation (Toro-Salazar et al. 2002).
Coronary heart disease was as common among patients and controls. This was 
somewhat surprising, as in some patient groups (COA, TGA with arterial switch) 
coronary problems have been reported to be frequent (Cohen et al. 1989, Legendre et 
al. 2003, Høimyr et al. 2007). 
The overall incidence of lethal endocarditis was only 0.07%. None of the deaths due 
to endocarditis occurred in patients with a valve prothesis, although these patients are 
believed to be at high risk (Horstkotte et al. 2004). The other two patient groups, those 
with aortic valve disease and those with cyanotic heart defect, had an increased risk 
for infective endocarditis, consistent with results of a previous study (Horstkotte et al. 
2004).
The incidence of deaths due to bleeding after anticoagulation therapy was very low 
among our patients, despite their use of large amounts of antithrombotic medicines. 
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The result confirmed the previously reported low incidence of fatal bleeding among 
young patients (Fitzmaurice et al. 2002). When only mortality for endocarditis and 
bleeding were considered, the artificial heart valve seemed to be a safe alternative for 
young patients.
Comorbidity and causes of non-CHD-related death
CHD patients had several chronic diseases and quite a big burden of medicines. The 
health problems clustered; the vast majority of CHD patients and also controls had no 
ESRs for medications of any disease, whereas one-fourth of CHD patients and one-
fifth of controls with one ESR also had other ESRs (≈chronic diseases). In addition, 
the use of antidepressants was most common among persons with chronic diseases. 
This connection was also described recently in the World Heath Surveys (Moussavi et 
al. 2007), and it should be kept in mind in everyday clinical work.
As in a recently published study of CHD children (Massin et al. 2007), the leading 
comorbid problems in our study, the subjects of which were mostly adolescents and 
adults, were genetic syndromes and neurological and pulmonary diseases.
The prevalence of mental retardation among Finnish patients operated on in 1953–
1989 was significantly lower than the 8.7% presented in Belgium (Massin et al. 2007). 
The difference was caused by the different eras of surgery; the Belgian patients 
were operated on during 1996–2006. In Finland during the 1990s, the proportion of 
mentally retarded patients was as high as 11%. During the early era patients with 
syndromes were not necessarily treated, and on the other hand increasingly critically ill 
children were treated in later years and their risk of having or subsequently sustaining 
neurological damages was higher.
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Patients had a high risk for epilepsy, and deaths due to neurological diseases occurred. 
Our study showed that the risk of epilepsy was high regardless of the type of surgery. 
Of the patients with epilepsy, one-fifth were operated on as neonates, and one-fifth 
were mentally retarded. The relation between intellectual disability and epilepsy was 
proven to be strong in a population-based study, where over half of the severely or 
profoundly retarded patients had epilepsy (Arvio et al. 2003). In our material, most 
retarded patients had chromosomal defects, but some of the retardation was also 
caused by cardiac defect or surgery. Hopefully, advancements in brain protection 
during surgery will result in better neurological outcomes in the future (Williams et al. 
2007).
Asthma prevalence was higher among patients than among controls. It was high even 
after exclusion of all patients operated on as neonates, whose risk for asthma was 
highest and mostly caused by prematurity (Jaakkola et al. 2006). Thus, it could be 
concluded that mature lungs were also damaged either because of the heart defect 
or the cardiac surgery. Open-heart surgery did not increase the risk of asthma in the 
patient population. This supports studies in which lung injuries after surgery were 
connected more often to blood transfusion and ventilation than to the cardiopulmonary 
bypass perfusion (Silliman et al. 2005, Groeneveld et al. 2007).
Among the causes of non-CHD-related deaths, the greatest difference between 
patients and the general population appeared in respiratory diseases. Pneumonia 
was the most common cause of respiratory death. High mortality due to pneumonia 
has often been associated with mental retardation (Patja et al. 2001) and seriously ill 
infants, as was also the case in our study.
81
Among Finnish CHD patients, the number of depressed and psychotic persons was 
slightly higher than among controls. The number of patients with psychiatric disorders 
did not differ by defect. This result contradicts previous findings of especially patients 
with severe CHD expressing anxiety and depression (Gupta et al. 1998, Popelova et 
al. 2001, Bromberg et al. 2003, van Rijen et al. 2004).
Although patients used more antidepressants than controls, the number of suicides 
was similar and equal to the number expected. Perhaps patients appreciated life more 
than controls and had learned to live with their difficulties. 
The number of accidental deaths was low. This may have resulted from the influence 
of parental over-protection, usually reported to cause only negative effects (Mahoney 
1991). One may also interpret this phenomenon as a reflection of the physical inability 
of the patients to engage in risky hobbies or physically demanding work that could lead 
to accidental death. Alternatively, patients with a chronic disease may appreciate life 
enough to avoid extreme hobbies and careless driving habits. This idea is supported 
by the finding that patients with rheumatoid arthritis very seldom died accidentally 
(Sihvonen et al. 2004). 
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Life after surgery
Subjectively, the vast majority of adult CHD patients who answered the questionnaire 
estimated their general health to be good. Poor health was usually associated with 
non-cardiac conditions. The overall health of patients within different diagnostic 
groups was similar of slightly worse than that previously reported (Horneffer et al. 
1990, Gersony et al. 1993, Meijboom et al. 1994, Meijboom et al. 1995, Kamphuis et 
al. 2002, Moons et al. 2004, Welke et al. 2007). 
The overall exercise tolerance of the operated patients was also good. Most patients 
were assigned to NYHA classes I and II in all diagnostic groups. Our results were 
comparable with earlier reports of patients with COA (Cohen et al. 1989) and VSD 
(Lillehei et al. 1992, Gersony et al. 1993). Both similar (Shampaine et al. 1989, Nollert 
et al. 1997) and better (Jonsson 1995, Bacha et al. 2001) exercise tolerance has been 
reported previously after TOF repair. Our patients with late corrective surgery or only 
palliative surgery worsened the estimated exercise capacity result of all TOF patients. 
Patients had coped surprisingly well with their defects. Their level of education was 
equivalent, and employment level even higher than expected, and they lived in a 
steady relationship as often as the general population. 
A high level of education has been reported frequently in several studies of different 
diagnostic groups (Lillehei et al. 1986, Lillehei et al. 1992, Gersony et al. 1993, Ternestedt 
et al. 2001). In our study, the number of patients with vocational or university education 
was higher than expected when the mentally retarded patients were excluded. 
However, we found that patients with TOF, TGA and UVH were less likely to have 
graduated from a university. Whether this was caused by lack of encouragement or a 
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decreased capacity for performance remains obscure. In a Dutch study, a surprisingly 
large proportion (27%) of patients had attended special education, and especially 
those with TOF and TGA ended up with a lower education level (van Rijen et al. 2003).
Patients were employed more often than expected. Even the employment level of the 
patients with cyanotic defects was comparable with that of the general population. 
The low unemployment rate reflected the high value of work among these patients, 
a finding reported also previously (Utens et al. 1994, Horner et al. 2000). The lower-
than-expected unemployment level could be caused by most heart patients who 
were unable to work probably being retired. Among the general population, it is quite 
common that persons are categorized as unemployed although they should be retired 
due to disability. 
Marital status of CHD patients was comparable with that of the general population, 
consistent with Dutch and Swedish studies (Ternestedt et al. 2001, van Rijen et al. 
2003). The low divorce rate among patients could be a sign of either successful 
relationships or over-adherence and lack of independence. Our data do not provide 
an answer to this interesting matter.
Patients did not have children as often as the general population, a tendency also seen 
previously (Gersony et al. 1993). A Dutch study contradicts these results, reporting 
that patients in the age group 25–39 years had children as often as their reference 
group (van Rijen et al. 2003). The younger patients (20–24 years) and the oldest 
patients (>40 years) also in that study also had less children than expected (van Rijen 
et al. 2003).
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Patients’ risk of having a child with congenital heart defect was 2.4 times higher than 
expected. As in previous studies, the recurrence of a CHD had varied widely between 
different defects. Patients with TOF and TGA have repeatedly reported not having 
children with CHD (Miyamura et al. 1993, Clarkson et al. 1994, Jonsson 1995, Genoni 
et al. 1999, Zuber et al. 1999), whereas the patients with minor lesions have had 
children with CHD about three times more often than expected (Lillehei et al. 1992, 
Driscoll et al. 1993, Zuber et al. 1999). The overall risk of only 2–3 out of 100 children 
can be considered small enough to encourage these patients to have offspring. 
However, they should also be provided with sufficient genetic counselling and prenatal 
cardiac investigations.
The majority of the adult patients were not in any planned, regular cardiac follow-up. 
As previously reported, the problem is not only common but also hazardous (Gersony 
et al. 1993, Jonsson 1995, Meijboom et al. 1995, Somerville 1997). Unfortunately, 
at the same time it is an undeniable fact that if all patients needing cardiac follow-up 
attended outpatient clinics, there would be a serious lack of resources. In Finland, 
none of the 12 cardiologists with expertise in this field work solely with CHD patients. 
The leading centre of CHD cardiology in Finland (HUS, Department of Cardiology) can 
offer only ten outpatient visits per week. In the future the lack of resourses will grow 
further. The constantly increasing number of adults with CHD has been described as a 
huge challenge for the health care system in USA (Dearani et al. 2007). In Finland, we 
face the same challenge, and actions to cope with this should be initiated immediately 
to ensure good heath care not only for children with congenital heart defects but also 
for these individuals in adulthood.
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CONCLUSIONS
1.	 Advancements	 in	 cardiac	 surgery	 and	 other	 treatments	 for	 CHD	 have	 been	
great.	During	the	first	37	years	treatment	has	improved	patients’	survival	from	
the	natural	 15-year	 survival	 of	67%	 to	a	45-year	 survival	 of	78%.	Survival	 of	
operated	 CHD	 patients	 was	 15%	 lower	 than	 that	 of	 the	 general	 population.	
Practically	all	CHDs	can	today	be	operated	on,	with	low	early	and	most	probably	
also	late	mortality.	
2.	 Many	patients	had	cardiac	problems;	16%	needed	several	operations	and	17%	
cardiac	medicines	 to	maintain	 their	 physical	 condition.	 Comorbidity	 was	 also	
quite	common.	Altogether	4-11%	(depending	on	the	era	of	surgery)	of	patients	
were	mentally	retarded.	The	risk	of	epilepsy	and	asthma	was	twice	as	high	as	
among	the	control	population.
3.	 The	majority	of	late	deaths	(67%)	were	attributed	to	patients’	CHD.	Of	the	cardiac	
deaths,	 40%	were	 caused	 by	 heart	 failure.	The	 leading	 causes	 of	 non-CHD-
related	deaths	were	respiratory	and	neurological	diseases.	
4.	 Most	 patients	 lived	 a	 normal	 life.	 They	 considered	 their	 general	 health	 and	
exercise	ability	to	be	good.	Their	education	level	was	similar	to	that	of	the	general	
population.	Most	patients	were	employed	and	had	grounded	a	family.
Most	of	the	operated	patients	should	be	in	cardiac	follow-up	for	the	rest	of	their	
lives.	 However,	 as	 the	 study	 showed,	many	 patients	 drop	 out.	A	 determined	
effort	should	be	made	to	develop	an	efficient	chain	of	services,	ensuring	a	safe	
transition	of	patients	from	paediatric	to	adult	cardiac	follow-up.	The	number	of	
adults	with	CHD	is	growing	rapidly	and	care	facilities	are	already	undersized.	
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